Valuation dashboard for Entrada Therapeutics, Inc. (TRDA) with P/E N/A, P/B 1.22, EV/EBITDA -1.37 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range of neuromuscular ailments. The company leverages its proprietary EEV platform to cultivate a rich pipeline of therapeutic programs, integrating oligonucleotide, antibody, and enzyme-based approaches.
Analysis Summary
Trailing-twelve-month margins: gross margin -7.5%, operating margin -37.7%, net margin -35.4%.
At the current price of $6.89, TRDA has negative trailing earnings (P/E not meaningful) and an ROE of -57.61%. Market capitalisation stands at $267M.
Balance sheet quality for TRDA: current ratio of 12.5. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.22 |
| EV / EBITDA | -1.37 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | $267M | 1.22 | -57.6% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.6B | 29.76 | 6.46 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $6.89 |
| Market Cap | $267M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -57.61% |
| Return on Invested Capital | -62.61% |
| Return on Assets | -55.47% |
| Gross Margin | -754.72% |
| Operating Margin | -3767.07% |
| Net Margin | -3537.73% |
Related companies: ACHV · ALLO · ARCT · AVIR · CAPR · HUMA · IMRX
Explore sector: Healthcare · Biotechnology
More sections of TRDA: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks